Medicare Enrolled

Dr. Rajiv Dattatreya, M.D.

Endocrinology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
10260 N CENTRAL EXPY STE 100N, Dallas, TX 75231
2143635535
In practice since 2006 (19 years)
NPI: 1801820113 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dattatreya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dattatreya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dattatreya

Dr. Rajiv Dattatreya is an endocrinology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dattatreya performed 2,382 Medicare services across 1,776 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dattatreya received a total of $541,841 from 72 pharmaceutical and/or device companies across 1641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dattatreya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in TX $541,841 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,382
Medicare services
Top 19% in TX for endocrinology
1,776
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~125 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 394 $94 $235
Blood draw (venipuncture) 259 $8 $12
Thyroid stimulating hormone (TSH) test 214 $16 $50
Comprehensive metabolic blood panel 204 $10 $57
Hemoglobin A1c test (diabetes monitoring) 195 $10 $48
Lipid panel (cholesterol and triglycerides) 182 $13 $54
Free thyroxine (T4) test 145 $9 $87
Complete blood count (CBC) with differential 132 $8 $20
Office visit, established patient, complex (40-54 min) 83 $126 $319
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 78 $26 $76
Basic metabolic blood panel 56 $8 $38
New patient office visit, complex (60-74 min) 56 $153 $452
Automated urinalysis 55 $2 $14
Bone density scan (DEXA) 49 $38 $322
Urinalysis, manual 43 $3 $13
Diabetes outpatient self-management training services, individual, per 30 minutes 40 $38 $125
Parathyroid hormone level test 36 $40 $143
New patient office visit (45-59 min) 33 $130 $358
Testosterone (hormone) level, free 21 $25 $109
Testosterone (hormone) level, total 21 $25 $129
Sex hormone binding globulin (protein) level 19 $21 $58
Vitamin D level test 15 $29 $182
Creatinine test (kidney function) 14 $5 $40
Uric acid level test 14 $4 $19
Cortisol (hormone) measurement, total 13 $16 $66
Urine microalbumin (protein) analysis 11 $6 $13
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$541,841
Total received (2018-2024)
Avg $77,406/year across 7 years
Top 5% in TX for endocrinology
72
Companies
1,641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$529,119 (97.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,075 (1.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,646 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$50,302
2023
$25,312
2022
$30,192
2021
$38,837
2020
$40,697
2019
$100,209
2018
$256,293

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$209,582
SANOFI-AVENTIS U.S. LLC
$170,745
Lilly USA, LLC
$58,337
Boehringer Ingelheim Pharmaceuticals, Inc.
$41,480
AstraZeneca Pharmaceuticals LP
$27,958
Janssen Pharmaceuticals, Inc
$15,425
MannKind Corporation
$3,003
AbbVie Inc.
$2,922
Merck Sharp & Dohme Corporation
$2,108
Amgen Inc.
$1,491
AbbVie, Inc.
$1,291
Mannkind Corporation
$682
Abbott Laboratories
$603
Insulet Corporation
$589
Amarin Pharma Inc.
$429
Radius Health, Inc.
$355
Dexcom, Inc.
$331
Amneal Pharmaceuticals LLC
$311
Xeris Pharmaceuticals, Inc.
$265
Embecta Corp.
$228
Bayer HealthCare Pharmaceuticals Inc.
$227
Alexion Pharmaceuticals, Inc.
$204
Becton, Dickinson and Company
$199
PFIZER INC.
$179
Merck Sharp & Dohme LLC
$168
ABBVIE INC.
$165
Averitas Pharma Inc.
$159
Esperion Therapeutics, Inc.
$132
Antares Pharma, Inc.
$122
Ascensia Diabetes Care US Inc.
$115
CeQur Corporation
$115
IBSA Pharma Inc.
$103
Alvogen Inc
$99
Amryt Pharma Holdings Ltd
$91
Shire North American Group Inc
$88
Corcept Therapeutics
$88
Endo Pharmaceuticals Inc.
$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Currax Pharmaceuticals LLC
$85
BIOTRONIK INC.
$85
Rhythm Pharmaceuticals, Inc.
$77
Tandem Diabetes Care, Inc.
$66
Avvisto Therapeutics, LLC
$63
VIVUS, Inc.
$62
Medtronic, Inc.
$60
Boston Scientific Corporation
$54
Ultragenyx Pharmaceutical Inc.
$51
LIFESCAN, INC.
$47
GRT US Holding, Inc.
$45
Zealand Pharma US, Inc.
$44
Kowa Pharmaceuticals America, Inc.
$40
Kyowa Kirin, Inc.
$38
Novartis Pharmaceuticals Corporation
$34
Horizon Therapeutics plc
$33
DEXCOM, INC.
$33
Gilead Sciences, Inc.
$31
Acerus Pharmaceuticals Corporation
$30
Neurocrine Biosciences, Inc.
$30
RECORDATI_RARE_DISEASES_INC.
$29
Eisai Inc.
$28
Ascendis Pharma Inc
$27
BETA BIONICS, INC.
$25
Chiesi USA, Inc.
$23
Ascensia Diabetes Care Us Inc.
$20
Allergan Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Valeritas, Inc.
$17
Medtronic MiniMed, Inc.
$16
VIVUS LLC
$14
Clarus Therapeutics Inc.
$12
Aytu BioScience, Inc
$12
Althera Pharmaceuticals LLC
$5
Top 3 companies account for 81.0% of total payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · BYSTOLIC · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · Cryvista · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · NASCOBAL · NATPARA · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · Natesto · ONETOUCH VERIO FLEX · Omnipod · Ozempic · PREVNAR 20 · Prolia · QSYMIA · QUTENZA · Qsymia · Qutenza · RYBELSUS · Repatha · Roszet · Rybelsus · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Sogroya · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · rezum Generator · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for endocrinology in TX.

Equivalent to $22,747 per 100 Medicare services performed
Looking for an endocrinology specialist in Dallas?
Compare endocrinologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
97
Per 100K population
3.7
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dattatreya is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 5% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dattatreya experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dattatreya performed 394 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dattatreya receive payments from pharmaceutical companies?
Yes. Dr. Dattatreya received a total of $541,841 from 72 companies across 1,641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dattatreya's costs compare to other endocrinologists in Dallas?
Dr. Dattatreya's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dattatreya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →